Daiichi Sankyo (OTCMKTS:DSNKY) Hits New 1-Year Low – Time to Sell?

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY) shares hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $18.9620 and last traded at $19.02, with a volume of 81786 shares changing hands. The stock had previously closed at $19.8460.

Wall Street Analysts Forecast Growth

Separately, Zacks Research lowered shares of Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 19th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

Daiichi Sankyo Trading Down 4.3%

The firm has a market cap of $35.99 billion and a P/E ratio of 17.92. The business’s 50-day moving average is $22.06 and its two-hundred day moving average is $23.60. The company has a current ratio of 2.31, a quick ratio of 1.60 and a debt-to-equity ratio of 0.06.

Daiichi Sankyo Company Profile

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.